Abuse-Deterrent Opioids

(4:30)

What Data Exist to Show Abuse-Deterrent Opioid Formulations Are Effective?

(1:11)

Abuse Deterrent Formulations

(3:37)

The Mechanisms of Abuse-Deterrent Opioids

(30)

The Benefits of Abuse-Deterrent Opioids

(56)

Abuse-deterrent Formulations of Opioids

(13:10)

Maximizing the Benefits of Abuse Deterrent Opioids

(6:41)

How Can You Tell Whether an Opioid Is Abuse-Deterrent?

(1:18)

They Define You to Control You: Weaponizing Identity in Abuse

(9:59)

Abuse Deterrent Opioids

(10:12)

PK/PD Meta-analysis of Abuse Deterrent Opioid Drugs (30of35) Complex Generics – Sep. 25-26, 2019

(14:39)

The Challenges Facing Abuse-Deterrent Opioids

(45)

Abuse Deterrent Formulations and Opioid Risk

(4:28)

How it Works: Abuse Deterrence Technology

(2:24)

PSA: Why Abuse Deterrent Formulations are a Solution

(56)

ICER Abuse-deterrent Opioid Interview

(4:11)

Understanding Abuse-Deterrent Opioid Technology Clinical Presentation

(15:59)

Abuse-Deterrent Approaches for Opiate Abuse - Dr. Krakower

(1:42)

Noble Fund Research aims to create abuse deterrent opioid prodrugs with lowered addiction potential

(2:15)

Putting Patients First: Developing Abuse-Deterrent Opioids Clinical Presentation

(11:27)